Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
193.20    0.60 (0.31%)
Bid:
193.20
Ask:
193.80
Spread: 0.60 (0.311%)
Market Cap: £516.00m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Trading Update

7 Jan 2014 07:00

RNS Number : 0232X
Costain Group PLC
07 January 2014
 



Costain Group PLC

("Costain" or "the Group" or "the Company")

 

Pre-Close Trading Update

 

Costain, a leading UK engineering solutions provider, today announces its pre-close trading update for the year ended 31 December 2013, ahead of its preliminary results for the period which will be announced on Thursday 13 March 2014.

 

Trading Update

 

Since the announcement of the Group's Interim Management Statement on 5 November 2013, Costain has continued to perform strongly and consequently expects to deliver a full-year result in line with the Board's expectations. In addition, as announced on 20 December 2013, the Group has realised a profit of £9.1 million from the sale of its minority shareholdings in three joint venture companies to Severn Trent PLC as part of the continuing disposal of its PFI equity portfolio. 

 

As a result of new contract wins and extensions, including the landmark AMP6 programme for Thames Water, the Hinkley Point C nuclear power station project, and a number of additional contracts for Crossrail, the Group finished the year with a high quality order book up 25% at £3.0 billion (2012: £2.4 billion) of which over 90% is repeat orders, providing good long-term revenue visibility. In excess of £750 million of work has been secured for 2014 (2012: in excess of £700 million secured for 2013).

 

In addition, Costain has a strong preferred bidder position on contracts worth over £400 million, and the level of tendering activity across the Group's targeted markets remains high.

 

The Group finished the year with a positive net cash position.

 

At the period end, the Group acquired the 27% interest from its partner Serco plc in their Managed Motorway Technology joint venture arrangement for a cash consideration of £2.4 million. The joint venture arrangement, in which Costain already held the remaining 73% interest, has a place on the Highways Agency framework to deliver new technology-led highways improvements.

 

Andrew Wyllie, Chief Executive, commented:

 

"We are delighted to finish the year with a very strong order book. Our continued success is the direct result of our focus on delivering innovative engineering solutions for blue chip customers who are investing in meeting national needs."

 

 

7 January 2014

 

 

 Enquiries:

 

Costain

Tel: 01628 842 444

Andrew Wyllie, Chief Executive

Tony Bickerstaff, Finance Director

Graham Read, Communications Director

College Hill

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUNSBRSAAARAR
Date   Source Headline
28th Oct 20252:48 pmRNSHolding(s) in Company
27th Oct 20252:47 pmRNSHolding(s) in Company
24th Oct 202512:05 pmRNSHolding(s) in Company
21st Oct 20254:13 pmRNSHolding(s) in Company
17th Oct 20255:07 pmRNSHolding(s) in Company
17th Oct 202511:26 amRNSHolding(s) in Company
14th Oct 20253:34 pmRNSAdditional Listing
13th Oct 202511:42 amRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSCostain Secures £1bn Programme With Sellafield
6th Oct 202510:59 amRNSHolding(s) in Company
18th Sep 20252:00 pmRNSScrip Dividend Reference Price
1st Sep 202511:07 amRNSTotal Voting Rights
28th Aug 20259:05 amRNSDirector/PDMR Shareholding
22nd Aug 20253:28 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHalf-year Report
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20259:07 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20255:23 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20252:39 pmRNSHolding(s) in Company
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202510:47 amRNSHolding(s) in Company
1st Aug 202510:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202510:40 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20253:03 pmRNSHolding(s) in Company
29th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSInvestor Presentation via Investor Meet Company
28th Jul 20252:11 pmRNSHolding(s) in Company
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20252:25 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 202511:03 amRNSHolding(s) in Company
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 202510:41 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.